Ryvu Therapeutics S.A. (WSE:RVU)
Poland
· Delayed Price · Currency is PLN 31.50
-0.90 (-2.78%)
Apr 24, 2025, 4:45 PM CET
Ryvu Therapeutics Revenue
In the year 2024, Ryvu Therapeutics had annual revenue of 101.96M PLN with 51.51% growth. Ryvu Therapeutics had revenue of 28.49M in the quarter ending December 31, 2024, with 60.89% growth.
Revenue
101.96M
Revenue Growth
+51.51%
P/S Ratio
7.18
Revenue / Employee
310.86K
Employees
328
Market Cap
731.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 101.96M | 34.67M | 51.51% |
| Dec 31, 2023 | 67.30M | -1.14M | -1.67% |
| Dec 31, 2022 | 68.44M | 33.02M | 93.25% |
| Dec 31, 2021 | 35.41M | -1.54M | -4.16% |
| Dec 31, 2020 | 36.95M | 3.23M | 9.58% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 12.61B |
| Synektik Spólka Akcyjna | 556.63M |
| Voxel | 507.77M |
| Celon Pharma | 209.54M |
| Selvita | 345.76M |
| Centrum Medyczne ENEL-MED | 680.32M |
| Scope Fluidics | 119.00K |
| EMC Instytut Medyczny | 809.41M |